https://www.selleckchem.com/pr....oducts/crenolanib-cp
CHA DS -VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We sought to study if this score predicts outcomes in elderly patients with Non-ST segment Elevation Acute Coronary Syndromes (NSTEACS). The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEACS aged≥80years. Data to calculate CHA DS -VASc Score were available in 523 patients (98.3%). They were classified according to CHA DS -VASc Score group 1 (score≤4), and 2 (5-9). We studied ou
Like
Comment
Share
